Note: Ingredients listed on restricted chemical lists
EC/CAS
111-76-2
Name of the chemical
Ethylene glycol monobutyl ether (EGBE)
Concentration
1-5
EC/CAS
25322-69-4
Name of the chemical
polypropyleneglycol
Concentration
1-5
General Information
Version
3
Revision date
2025-12-21
Product name
61RQH - BLEU IRON REVOZ
1.2.1 Relevant identified uses
Industrial applications, Professional applications
Manufacturer Name
PPG Industries, Inc
Icons in SDS
Company Information
company name
PPG Industries, Inc
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H227, H317
Hazard statements
Code
Statements
H227
Combustible liquid
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
Ingredient(s) with unknown acute toxicity
11.6% (oral), 16.2% (dermal), 22.5% (inhalation)
Signal word
Warning
Hazard statements
Combustible liquid.
Prevention
Wear protective gloves, protective clothing and eye or face protection. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.
Response
Not applicable.
Storage
Not applicable.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
Contains isothiazolinones. May cause allergic reaction. Sanding and grinding dusts may be harmful if inhaled. Repeated exposure to high vapor concentrations may cause irritation of the respiratory system and permanent brain and nervous system damage. Inhalation of vapor/aerosol concentrations above the recommended exposure limits causes headaches, drowsiness and nausea and may lead to unconsciousness or death. This product either contains formaldehyde or is capable of releasing formaldehyde above 0.5 ppm under certain conditions. Formaldehyde is a known cancer hazard, a skin sensitizer and a respiratory sensitizer. Emits toxic fumes when heated.
2.3 Other hazards
None known.
2.1 Classification of the substance or mixture
Percentage of the mixture consisting of ingredient(s) of unknown acute toxicity: 11.6% (oral), 16.2% (dermal), 22.5% (inhalation)